Carillon Tower Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$26.2M	Buy	+201,572	New	+$26.2M	0.16%	192
2020 Q3	–	Sell	-201,572	Closed	-$29.9M	–	438
2020 Q2	$29.9M	Buy	+201,572	New	+$29.9M	0.23%	137